Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Nuclear Medicine Communications|August 11, 2022
Integrated 18F-FDG PET/CT parameter defines metabolic oligometastatic non-small cell lung cancerRong Ma, Qian Zhao, Ren Zhao, et al.
American Journal of Translational Research|May 18, 2016
The therapeutic response of CDDO-Me in the esophageal squamous cell carcinoma (ESCC) cells is mediated by CaMKIIαYan-Yang Wang, Shun Zhou, Ren Zhao, et al.
Frontiers in Oncology|April 1, 2021
Lymphopenia in Esophageal Cancer: What Have We Learned?Jia-Lin Wang, Rong Ma, Wei Kong, et al.
Oxidative Medicine and Cellular Longevity|April 20, 2018
Nrf2-Mediated Metabolic Reprogramming in CancerYan-Yang Wang, Juan Chen, Xiao-Ming Liu, et al.
Radiation Oncology (London, England)|October 17, 2014
VMAT planning study in rectal cancer patientsJun Shang, Wei Kong, Yan-yang Wang, et al.
Cancer Cell International|August 29, 2021
The role of the deubiquitinating enzyme DUB3/USP17 in cancer: a narrative reviewGuang-Fei Yang, Xin Zhang, Yi-Ge Su, et al.
Radiation Oncology (London, England)|December 25, 2012
ERCC1 mRNA levels can predict the response to cisplatin-based concurrent chemoradiotherapy of locally advanced cervical squamous cell carcinomaZhou-lan Bai, Yan-yang Wang, Hong Zhe, et al.
Molecular Neurobiology|December 23, 2025
APOE Lipoprotein Particles: Pathophysiology, Therapy, and the Crosstalk in Alzheimer's Disease and Cardiovascular DiseaseChan Liu, Juan Liu, Yan-Yang Wang, et al.
Drug Design, Development and Therapy|November 4, 2014
Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic propertiesYan-Yang Wang, Yin-Xue Yang, Hong Zhe, et al.
Disease Markers|September 6, 2019
Prognostic Value of Combined Analysis of CTLA-4 and PLR in Esophageal Squamous Cell Carcinoma (ESCC) PatientsCui-Ying Zhang, Juan Zhang, Yun-Fan Ma, et al.
Pageof 4